July 10th 2025
Gilead Sciences has partnered with the Global Fund to supply up to 2 million doses of its long-acting HIV prevention drug, lenacapavir, to low and lower-middle income countries.
Less Adolescents May Use STD Services Fearing Parents Could Find Out
March 16th 2017CDC researchers examine STD services and confidentiality issues among individuals between 15 and 25 years of age and find that not spending time alone with a healthcare provider, without a parent in the room, may limit use of STD services for some youths.
Read More
Study Finds Nurse-Delivered Intervention Program Significantly Improves HIV-Treatment Adherence
March 16th 2017Adherence with HIV therapy regimens remains difficult for some patients. Nurse-delivered interventions can increase adherence, reduce disease costs, and extend the lifespan in an HIV-infected population.
Read More
National Women & Girls HIV/AIDS Awareness Day: Let's Break the Stigma
March 11th 2017March 10, 2017 marks the 12th observance of National Women and Girls HIV/AIDS Awareness Day, a day that is dedicated to raising awareness about the impact of HIV/AIDS on women and girls and encouraging them to take action when it comes to preventing infection.
Read More
Chlamydia Vaccine: A Costly Solution to STD-Related Morbidity & Mortality
March 10th 2017At the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers presented findings that suggested that a chlamydia vaccine, although costly, can avert significant morbidity.
Read More
As Perceived AIDS Threat Diminishes, MSM Engage in Riskier Sex
February 22nd 2017A survey spanning almost two decades shows a consistent increase in condom-less anal sex and number of sexual partners in MSM as many see antiretroviral therapy as a "protective back-up" measure to avoid HIV infection.
Read More